New and updated respiratory syncytial virus (RSV) resources

August 13, 2025

The Australian Government Department of Health, Disability and Aging (the department) has released a number of updated resources to support the correct administration of RSV vaccines and monoclonal antibodies.

A single dose of the RSV vaccine, Abrysvo®, is recommended for women at 28 to 36 weeks of pregnancy and is available for free through the National Immunisation Program (NIP).

  • Arexvy® must not be administered to pregnant women.
  • Victoria is offering the RSV monoclonal antibody, Beyfortus™ (Nirsevimab) for free to eligible infants and children.
  • Abrysvo® and Arexvy® must not be administered to infants or children.
  • The department has produced a poster outlining the correct administration of RSV vaccines and monoclonal antibodies by cohort.

Updated resources include:

For more information visit - Respiratory syncytial virus (RSV) vaccine | Australian Government Department of Health, Disability and Ageing

Latest news

September 23, 2025
General Practices have a new way to manage and report on visits to patients in aged care with the release of the Puffin tool, developed specifically to support the General Practice in Aged Care Incentive (GPACI).
September 23, 2025
Changes to bulk billing incentives from 1 November 2025 will expand the eligibility of bulk billing incentives to all Australians with a Medicare card.
September 17, 2025
Learn healthy ways to manage life’s challenges and cope with sadness, worry and anxiety.